New FDA Policies Shape Pharma Development and Production
News
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-02-2005
Volume 29
Issue 5
FDA is finalizing guidances and enforcing compliance with manufacturing standards as part of its efforts to ensure drug safety.
Articles in this issue
Scalable Membrane Ion-Exchange Chromatography Purification of an Antisense Oligonucleotide
New Vaccine Technologies Carry and Deliver by Kaylynn Chiarello
GenerationNext
New Vaccine Technologies Carry and Deliver
High Molecular Weight Polyethylene Oxide-Based Drug Delivery Systems - Part I: Hydrogels and Hydrophilic Matrix Systems
May 2005
Bar Coding Deadline Looms
In the Spotlight - May 2005
New FDA Policies Shape Pharma Development and Production
Automating HPLC and GC Analytical Method Validation
Price Matters
Recent Videos
Related Content
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Article
Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
